An executive ousting, an entire dermatology unit in freefall, a mass exodus of 950 employees, and a high-stakes EOW criminal complaint. As Emcure hits the $1.1 billion milestone, an explosive internal war threatens to rewrite the rules of domestic pharma dominance. As boardroom battles